Northeast Pharmaceutical Group Co Ltd (000597) — Financial Flexibility Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥285.57 Million (operating CF CN¥274.09 Million minus capex CN¥11.48 Million) represents 0% of total liabilities (CN¥8.05 Billion). Check 000597 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Northeast Pharmaceutical Group Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Northeast Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Northeast Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Northeast Pharmaceutical Group Co Ltd. Explore Northeast Pharmaceutical Group Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥1.20 Billion | CN¥1.11 Billion | CN¥7.22 Billion | ▲ +61.2% |
| 2024 | 0.10x | CN¥918.19 Million | CN¥758.76 Million | CN¥8.88 Billion | ▲ +27.3% |
| 2023 | 0.08x | CN¥822.18 Million | CN¥586.75 Million | CN¥10.11 Billion | ▼ -45.3% |
| 2022 | 0.15x | CN¥1.35 Billion | CN¥1.11 Billion | CN¥9.10 Billion | ▲ +52.6% |
| 2021 | 0.10x | CN¥866.31 Million | CN¥746.51 Million | CN¥8.89 Billion | ▼ -19.3% |
| 2020 | 0.12x | CN¥971.30 Million | CN¥570.92 Million | CN¥8.04 Billion | ▲ +79.0% |
| 2019 | 0.07x | CN¥581.77 Million | CN¥352.60 Million | CN¥8.62 Billion | ▼ -35.6% |
| 2018 | 0.10x | CN¥850.83 Million | CN¥285.09 Million | CN¥8.13 Billion | ▲ +642.6% |
| 2017 | 0.01x | CN¥113.43 Million | CN¥-301.20 Million | CN¥8.05 Billion | ▼ -81.5% |
| 2016 | 0.08x | CN¥561.52 Million | CN¥384.51 Million | CN¥7.36 Billion | ▲ +7.7% |
| 2015 | 0.07x | CN¥445.74 Million | CN¥99.70 Million | CN¥6.29 Billion | ▼ -28.9% |
| 2014 | 0.10x | CN¥579.26 Million | CN¥46.99 Million | CN¥5.81 Billion | ▲ +219.8% |
| 2013 | 0.03x | CN¥185.64 Million | CN¥-266.38 Million | CN¥5.96 Billion | ▼ -50.1% |
| 2012 | 0.06x | CN¥264.99 Million | CN¥86.09 Million | CN¥4.24 Billion | ▲ +36.9% |
| 2011 | 0.05x | CN¥188.33 Million | CN¥-233.32 Million | CN¥4.13 Billion | ▼ -77.9% |
| 2010 | 0.21x | CN¥729.89 Million | CN¥255.96 Million | CN¥3.54 Billion | ▼ -43.9% |
| 2009 | 0.37x | CN¥1.48 Billion | CN¥615.91 Million | CN¥4.03 Billion | ▼ -13.0% |
| 2008 | 0.42x | CN¥1.07 Billion | CN¥709.03 Million | CN¥2.53 Billion | ▲ +218.9% |
| 2007 | 0.13x | CN¥286.34 Million | CN¥198.56 Million | CN¥2.16 Billion | ▲ +391.5% |
| 2006 | -0.05x | CN¥-58.16 Million | CN¥-106.00 Million | CN¥1.28 Billion | ▼ -129.5% |
| 2005 | 0.15x | CN¥215.06 Million | CN¥111.40 Million | CN¥1.40 Billion | ▼ -12.4% |
| 2004 | 0.18x | CN¥272.20 Million | CN¥211.06 Million | CN¥1.55 Billion | ▼ -8.7% |
| 2003 | 0.19x | CN¥317.54 Million | CN¥230.08 Million | CN¥1.65 Billion | ▲ +77.8% |
| 2002 | 0.11x | CN¥195.48 Million | CN¥157.41 Million | CN¥1.81 Billion | ▲ +61.5% |
| 2001 | 0.07x | CN¥125.42 Million | CN¥78.84 Million | CN¥1.87 Billion | ▲ +144.5% |
| 2000 | 0.03x | CN¥48.31 Million | CN¥36.13 Million | CN¥1.76 Billion | ▼ -25.9% |
| 1999 | 0.04x | CN¥64.03 Million | CN¥54.62 Million | CN¥1.73 Billion | ▲ +324.9% |
| 1998 | 0.01x | CN¥13.84 Million | CN¥-7.59 Million | CN¥1.59 Billion | — |